{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:29:15Z","timestamp":1793838555260,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejogrb.2023.06.016","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T11:16:08Z","timestamp":1687000568000},"page":"166-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Uterine sarcomas: A critical review of the literature"],"prefix":"10.1016","volume":"287","author":[{"given":"Andrea","family":"Giannini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullio","family":"Golia D'Aug\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bogani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Simone","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Chiantera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Vizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovico","family":"Muzii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violante","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2023.06.016_b0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2020.08.016","article-title":"Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa\u2019 italiana di Ginecologia E Ostetricia)","volume":"139","author":"Ferrandina","year":"2020","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.016_b0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D'Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0015","doi-asserted-by":"crossref","unstructured":"Hanby AM, Walker C. Tavassoli FA, Devilee P: Pathology and genetics: tumours of the breast and female genital organs. WHO Classification of Tumours series \u2013 Volume IV. Lyon, France: IARC Press. Breast Cancer Res 2004;6:133.","DOI":"10.1186\/bcr788"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0020","unstructured":"Gaillard S, Secord AA. Endometrial stromal sarcoma and related tumors and uterine adenosarcoma. UpToDate. Available at: https:\/\/www.uptodate.com\/contents\/endometrial-stromal-sarcoma-and-related-tumors-and-uterine-adenosarcoma (last accessed 19 February 2023)."},{"key":"10.1016\/j.ejogrb.2023.06.016_b0025","first-page":"113","article-title":"Outcome and prognostic factors of uterine sarcoma in 59 patients: single institutional results","volume":"22","author":"Nassar","year":"2010","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.016_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000080283","article-title":"Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan","volume":"67","author":"Sagae","year":"2004","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.016_b0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: a National Cancer Database study","volume":"145","author":"Seagle","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0040","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/CM9.0000000000000259","article-title":"Survival outcomes of different treatment modalities in patients with low-grade endometrial stromal sarcoma","volume":"132","author":"Wang","year":"2019","journal-title":"Chin Med J"},{"issue":"Supp 3","key":"10.1016\/j.ejogrb.2023.06.016_b0045","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/IGC.0000000000000205","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma","volume":"24","author":"Amant","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.016_b0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/IGC.0b013e31819a1f8f","article-title":"Uterine leiomyosarcoma: does the primary surgical procedure matter?","volume":"19","author":"Perri","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0055","unstructured":"Lebreton C, Meeus P, Genestie C, et al. [Endometrial stromal sarcoma: French Guidelines from the French Sarcoma Group and the Rare Malignant Gynecologic Tumors Group]. Bull Cancer 2023;S0007-4551(23)00141-8."},{"key":"10.1016\/j.ejogrb.2023.06.016_b0060","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bulcan.2023.01.009","article-title":"Uterine leiomyosarcoma \u2013 French guidelines from the GSF\/NETSARC and TMRG groups","volume":"110","author":"Collineau","year":"2023","journal-title":"Bull Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.06.016_b0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/gyno.1998.5124","article-title":"Fertility-sparing surgery in uterine leiomyosarcoma","volume":"70","author":"Lissoni","year":"1998","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.06.016_b0070","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ygyno.2013.12.032","article-title":"Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases","volume":"132","author":"Bai","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"22","key":"10.1016\/j.ejogrb.2023.06.016_b0075","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.3390\/cancers13225808","article-title":"Uterine preservation treatments in sarcomas: oncological problems and reproductive results: a systematic review","volume":"13","author":"Dondi","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.06.016_b0080","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0085","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/AOG.0b013e31818aa89a","article-title":"Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma","volume":"112","author":"Shah","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.016_b0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2010.12.363","article-title":"Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma","volume":"121","author":"dos Santos","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.06.016_b0095","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.23245","article-title":"Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy","volume":"112","author":"Kapp","year":"2008","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.06.016_b0100","first-page":"1140","article-title":"Is adnexectomy mandatory at the time of hysterectomy for uterine sarcomas? A systematic review and meta-analysis","volume":"58","author":"Ronsini","year":"2022","journal-title":"Med Kaunas Lith"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.06.016_b0105","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ygyno.2017.01.012","article-title":"Significance of lymph node metastasis on survival of women with uterine adenosarcoma","volume":"144","author":"Machida","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.06.016_b0110","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/IGC.0b013e3181b33c9a","article-title":"Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma?","volume":"19","author":"Barney","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0115","doi-asserted-by":"crossref","first-page":"101589","DOI":"10.1016\/j.suronc.2021.101589","article-title":"Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database","volume":"38","author":"Nasioudis","year":"2021","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejogrb.2022.10.013","article-title":"Prognostic significance of lymphadenectomy in uterine leiomyosarcomas and endometrial stromal sarcomas: systematic review and meta-analysis","volume":"279","author":"Li","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0125","unstructured":"National Comprehensive Cancer Network. NCCN guidelines for patients. Uterine cancer. Plymouth Meeting, PA: NCCN; 2021."},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.016_b0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4274\/jtgga.galenos.2022.2021.9-17","article-title":"Effect of tumor morcellation in patients with early uterine sarcoma: a multicenter study in Germany","volume":"23","author":"Gitas","year":"2022","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.06.016_b0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000317255","article-title":"The difference of the impacts of surgical approaches on cellular immunity in patients with uterine malignancies: a comparative study of laparoscopy and laparotomy surgery","volume":"71","author":"Zhang","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0140","unstructured":"US Food and Drug Administration. UPDATE: Perform only contained morcellation when laparoscopic power morcellation is appropriate: FDA Safety Communication. White Oak, MD: US FDA; 2020. Available at: https:\/\/www.fda.gov\/medical-devices\/safety-communications\/update-perform-only-contained-morcellation-when-laparoscopic-power-morcellation-appropriate-fda (last accessed 19 February 2023)."},{"key":"10.1016\/j.ejogrb.2023.06.016_b0145","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.critrevonc.2015.11.015","article-title":"Morcellation of undiagnosed uterine sarcoma: a critical review","volume":"98","author":"Bogani","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0150","unstructured":"US Food and Drug Administration. Product labeling for laparoscopic power morcellators. White Oak, MD: US FDA; 2020. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/product-labeling-laparoscopic-power-morcellators (last accessed 19 February 2023)."},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.016_b0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2014.11.011","article-title":"Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis","volume":"137","author":"Bogani","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.016_b0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygyno.2016.11.002","article-title":"Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: a retrospective MITO group study","volume":"144","author":"Raspagliesi","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.016_b0165","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ygyno.2003.10.044","article-title":"The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990\u20131999) at the Massachusetts General Hospital","volume":"92","author":"Dinh","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"02","key":"10.1016\/j.ejogrb.2023.06.016_b0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.36129\/jog.2022.34","article-title":"The role of preoperative frailty assessment in patients affected by gynecological cancer: a narrative review","volume":"34","author":"D\u2019Oria","year":"2022","journal-title":"Ital J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.016_b0175","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ygyno.2012.02.014","article-title":"Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis","volume":"125","author":"Leitao","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.06.016_b0180","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","article-title":"Clinical management of uterine sarcomas","volume":"10","author":"Amant","year":"2009","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.016_b0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2007.02.031","article-title":"Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma","volume":"106","author":"Giuntoli","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.016_b0190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2021.04.029","article-title":"Uterine serous carcinoma","volume":"162","author":"Bogani","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0195","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.3390\/jcm11164761","article-title":"Fertility-sparing management may be considered in young women with uterine sarcoma","volume":"11","author":"Pi\u0105tek","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.016_b0200","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/ijgc-2022-004073","article-title":"Endometrial carcinosarcoma","volume":"33","author":"Bogani","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0205","doi-asserted-by":"crossref","unstructured":"Nesrine T, Ines Z, Abdelwahed N, et al. Prognostic factors and the role of pelvic lymphadenectomy in uterine leiomyosarcomas. SAGE Open Med 2019;7:2050312119856817.","DOI":"10.1177\/2050312119856817"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0210","doi-asserted-by":"crossref","unstructured":"Denschlag D, Ackermann S, Battista MJ, et al. Sarcoma of the uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No.\u2009015\/074, April 2021). Geburtshilfe Frauenheilkd 2022;82:1337\u201367.","DOI":"10.1055\/a-1897-5124"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.06.016_b0215","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/13645706.2021.1982727","article-title":"Endobag use in laparoscopic gynecological surgeries: a systematic review","volume":"31","author":"Feghali","year":"2022","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"3-4","key":"10.1016\/j.ejogrb.2023.06.016_b0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000525624","article-title":"Transvaginal versus port-site specimen retrieval after laparoscopic myomectomy: a systematic review and meta-analysis","volume":"87","author":"Lagan\u00e0","year":"2022","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0225","unstructured":"Hartmann KE, Fonnesbeck C, Surawicz T, et al. Management of uterine fibroids. Rockville, MD: Agency for Healthcare Research and Quality; 2017. Available at: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537742\/ (last accessed 19 February 2023)."},{"issue":"4","key":"10.1016\/j.ejogrb.2023.06.016_b0230","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jmig.2016.01.021","article-title":"Morcellator\u2019s port-site metastasis of a uterine smooth muscle tumor of uncertain malignant potential after minimally invasive myomectomy","volume":"23","author":"Bogani","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ejogrb.2023.06.016_b0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.gore.2018.01.007","article-title":"The impact of morcellation on survival outcomes of undiagnosed uterine sarcoma","volume":"23","author":"Raspagliesi","year":"2018","journal-title":"Gynecol Oncol Rep"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.06.016_b0240","first-page":"3219","article-title":"An extremely rare case of disseminated peritoneal leiomyomatosis with a pelvic leiomyosarcoma and omental metastasis after laparoscopic morcellation: systematic review of the literature","volume":"12","author":"Vimercati","year":"2022","journal-title":"Diagn Basel Switz"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.06.016_b0245","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2019.07.002","article-title":"Uterine smooth muscle tumors of unknown malignant potential: a challenging question","volume":"154","author":"Gadducci","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.06.016_b0250","doi-asserted-by":"crossref","DOI":"10.1186\/s13569-020-00139-3","article-title":"Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers","volume":"10","author":"Fuc\u00e0","year":"2020","journal-title":"Clin Sarcoma Res"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.06.016_b0255","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ygyno.2016.07.110","article-title":"Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: a systematic review and meta-analysis","volume":"143","author":"Bogani","year":"2016","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523002580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523002580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:02:09Z","timestamp":1759557729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523002580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":51,"alternative-id":["S0301211523002580"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.06.016","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uterine sarcomas: A critical review of the literature","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}